EXACT Therapeutics AS (DE:56F) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EXACT Therapeutics AS has decided not to proceed with its planned Subsequent Offering of new shares and warrants after successfully raising NOK 145 million through a Private Placement. The company’s shares have been trading at or below the subscription price, providing shareholders ample opportunity to mitigate dilution effects. This decision reflects the company’s strategic adjustment based on current market conditions.
For further insights into DE:56F stock, check out TipRanks’ Stock Analysis page.